Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 11 | 9 | −2 |
| Shares | 504.3K | 134.8K | −369.5K (−73.3%) |
| Value | $2.32M | $264.6K | −$2.05M (−88.6%) |
New holders (3)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 16,899 | $33.0K | 0.00% |
| Two Sigma Securities, LLC | 16,468 | $32.3K | 0.00% |
| Goldman Sachs Group Inc | 12,429 | $24.4K | 0.00% |
Sold out (5)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| BlackRock Inc. | 308,137 | $1.41M |
| Jane Street Group, LLC | 20,968 | $96.0K |
| HSBC Holdings PLC | 13,737 | $67.0K |
| Barclays PLC | 8,410 | $39.0K |
| Royal Bank of Canada | 1 | $0 |